Titre:
  • Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Auteur:Van Cutsem, Eric; Peeters, Marc; Siena, Salvatore; Humblet, Yves; Hendlisz, Alain; Neyns, Bart; Canon, Jean-Luc; Van Laethem, Jean-Luc; Maurel, Joan; Richardson, Gary; Wolf, Michael; Amado, Rafael G
Informations sur la publication:Journal of clinical oncology, 25, 13, page (1658-1664)
Statut de publication:Publié, 2007-05
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Aged
Antibodies, Monoclonal -- adverse effects -- pharmacology -- therapeutic use
Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use
Colorectal Neoplasms -- drug therapy -- nursing -- pathology
Disease-Free Survival
Female
Humans
Immunohistochemistry
Male
Middle Aged
Neoplasm Metastasis
Receptor, Epidermal Growth Factor -- antagonists & inhibitors -- metabolism
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2006.08.1620
info:pii/25/13/1658
info:pmid/17470858